IFP Advisors, Inc - ALLOGENE THERAPEUTICS INC ownership

ALLOGENE THERAPEUTICS INC's ticker is ALLO and the CUSIP is 019770106. A total of 171 filers reported holding ALLOGENE THERAPEUTICS INC in Q1 2021. The put-call ratio across all filers is 0.29 and the average weighting 0.3%.

Quarter-by-quarter ownership
IFP Advisors, Inc ownership history of ALLOGENE THERAPEUTICS INC
ValueSharesWeighting
Q2 2021$0
-100.0%
0
-100.0%
0.00%
-100.0%
Q1 2021$115,000
+40.2%
3,2580.0%0.00%
-33.3%
Q4 2020$82,000
-33.3%
3,2580.0%0.00%
-57.1%
Q3 2020$123,000
-9.6%
3,2580.0%0.01%
-36.4%
Q2 2020$136,000
+103.0%
3,2580.0%0.01%
+57.1%
Q1 2020$67,000
-23.0%
3,2580.0%0.01%0.0%
Q4 2019$87,000
-2.2%
3,2580.0%0.01%
+16.7%
Q3 2019$89,000
-22.6%
3,258
-19.2%
0.01%
-62.5%
Q1 2019$115,0000.0%4,0330.0%0.02%0.0%
Q1 2016$115,0004,0330.02%
Other shareholders
ALLOGENE THERAPEUTICS INC shareholders Q1 2021
NameSharesValueWeighting ↓
Vida Ventures Advisors, LLC 1,798,163$45,386,0009.32%
TPG Group Holdings (SBS) Advisors, Inc. 18,716,306$472,400,0005.23%
Wildcat Capital Management, LLC 1,515,524$38,252,0004.81%
REGENTS OF THE UNIVERSITY OF CALIFORNIA 900,143$22,720,0003.28%
Coastal Bridge Advisors, LLC 385,824$9,738,0001.93%
Casdin Capital, LLC 945,000$23,852,0000.71%
DSAM Partners (London) Ltd 208,798$5,270,0000.62%
BAINCO INTERNATIONAL INVESTORS 152,839$3,858,0000.44%
Pier Capital, LLC 152,071$3,838,0000.41%
Woodline Partners LP 567,539$14,325,0000.38%
View complete list of ALLOGENE THERAPEUTICS INC shareholders